Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Alli (orlistat) capsules

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – September 2010

Summary View

 

WARNING

Stop use and ask a doctor if:
  • you develop itching
  • yellow eyes or skin
  • dark urine or loss of appetite
  • There have been rare reports of liver injury in people taking orlistat
-
-